Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (149)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

  3. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

  4. Therapeutic inertia in the management of neuromyelitis optica spectrum disorder

    Frontiers in Neurology , Vol. 15

  5. Vaccine Safety and Immunogenicity in Patients with Multiple Sclerosis Treated with Natalizumab

    JAMA Network Open, Vol. 7, Núm. 4, pp. E246345

2023

  1. A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients

    Multiple Sclerosis Journal

  2. Assessment of Upper Extremity Function in Multiple Sclerosis: Feasibility of a Digital Pinching Test

    JMIR Formative Research, Vol. 7

  3. Association of Early Progression Independent of Relapse Activity with Long-term Disability after a First Demyelinating Event in Multiple Sclerosis

    JAMA Neurology, Vol. 80, Núm. 2, pp. 151-160

  4. Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event

    Neurology, Vol. 101, Núm. 13, pp. E1280-E1292

  5. Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients

    European Journal of Neurology

  6. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness

    Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231

  7. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  8. Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

    NeuroImage: Clinical, Vol. 38

  9. Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report

    Frontiers in Neuroscience, Vol. 17

  10. Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia: revisión de la evidencia actual

    Revista de neurologia, Vol. 76, Núm. 1, pp. 21-30

  11. Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI

    Journal of Magnetic Resonance Imaging

  12. Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence, Vol. 17, pp. 1431-1439

  13. Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

    Annals of Neurology

  14. Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1624-1636

  15. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group

    Parkinson's Disease, Vol. 2023